VRNA

Verona Pharma
VRNA

Overview Fund Activity

9 hedge funds and large institutions have $46.1M invested in Verona Pharma in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NHAS
1
Novo Holdings A/S
Denmark
$8.64M
2
VC
2
Vivo Capital
California
$8.21M
3
NMC
3
NEA Management Company
Maryland
$7.77M
4
O
4
OrbiMed
New York
$7.77M
5
FCMI
5
Foresite Capital Management III
California
$7.15M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
NHAS
1
Novo Holdings A/S
Denmark
$8.64M 740,740 +740,740 New
VC
2
Vivo Capital
California
$8.21M 704,225 +704,225 New
NMC
3
NEA Management Company
Maryland
$7.77M 666,666 +666,666 New
O
4
OrbiMed
New York
$7.77M 666,666 +666,666 New
FCMI
5
Foresite Capital Management III
California
$7.15M 613,601 +613,601 New
TCM
6
Tekla Capital Management
Massachusetts
$3.21M 275,000 +275,000 New
PA
7
Perceptive Advisors
New York
$2.33M 200,000 +200,000 New
Fidelity International
8
Fidelity International
Bermuda
$873K 75,813 +75,813 New
Jane Street
9
Jane Street
New York
$133K 11,444 +11,444 New